These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17576863)

  • 1. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.
    McCrindle BW; Li JS; Minich LL; Colan SD; Atz AM; Takahashi M; Vetter VL; Gersony WM; Mitchell PD; Newburger JW;
    Circulation; 2007 Jul; 116(2):174-9. PubMed ID: 17576863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follow-up studies of Hokkaido residents with Kawasaki disease].
    Murakami H; Igarashi K; Urasawa K; Sakurai M; Sato M; Tagami S; Tsuchihashi K; Nakagawa T; Nishimura M;
    J Cardiol; 2003 Jan; 41(1):1-6. PubMed ID: 12564107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criterion for early prediction of coronary artery involvement by clinical manifestations in patients with Kawasaki disease.
    Ishihara H; Izumida N; Hosaki J
    Bull Tokyo Med Dent Univ; 1985 Jun; 32(2):77-89. PubMed ID: 3864563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease in a pediatric intensive care unit: a case-control study.
    Dominguez SR; Friedman K; Seewald R; Anderson MS; Willis L; Glodé MP
    Pediatrics; 2008 Oct; 122(4):e786-90. PubMed ID: 18809597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Kawasaki disease in infants younger than six months of age.
    Chang FY; Hwang B; Chen SJ; Lee PC; Meng CC; Lu JH
    Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center].
    Raith W; Gamillscheg A; Heinzl B; Nagel BH; Koestenberger M; Beitzke A
    Klin Padiatr; 2009; 221(2):83-8. PubMed ID: 19263328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery dilation after Kawasaki disease for children within the normal range.
    Crystal MA; Manlhiot C; Yeung RS; Smallhorn JF; McCrindle BW
    Int J Cardiol; 2009 Jul; 136(1):27-32. PubMed ID: 18619690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.
    de Ferranti SD; Gauvreau K; Friedman KG; Tang A; Baker AL; Fulton DR; Tremoulet AH; Burns JC; Newburger JW
    JAMA Pediatr; 2018 Dec; 172(12):e183310. PubMed ID: 30285057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections and Kawasaki disease: implications for coronary artery outcome.
    Benseler SM; McCrindle BW; Silverman ED; Tyrrell PN; Wong J; Yeung RS
    Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy.
    Nakano H
    Prog Clin Biol Res; 1987; 250():287-97. PubMed ID: 3423043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease.
    Sung RY; Ng YM; Choi KC; Mok GC; Cheng YW; Ho MH;
    Pediatr Infect Dis J; 2006 Jun; 25(6):521-5. PubMed ID: 16732150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dimensional echocardiographic recognition of coronary artery disease in Kawasaki disease. A case report.
    Pieroni DR; Slavich G; Gingell RL; Roland JM
    G Ital Cardiol; 1982; 12(7):524-9. PubMed ID: 7169149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of atypical Kawasaki disease.
    Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Chen HH; Wang L; Yang KD
    J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features in adults with coronary arterial lesions caused by presumed Kawasaki disease.
    Tsuda E; Matsuo M; Naito H; Noguchi T; Nonogi H; Echigo S
    Cardiol Young; 2007 Feb; 17(1):84-9. PubMed ID: 17244380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.
    Millar K; Manlhiot C; Yeung RS; Somji Z; McCrindle BW
    Int J Cardiol; 2012 Jan; 154(1):9-13. PubMed ID: 20851480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T; Inoue Y; Morikawa A
    Nihon Rinsho; 2008 Feb; 66(2):332-7. PubMed ID: 18260333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline
    Son MBF; Gauvreau K; Kim S; Tang A; Dedeoglu F; Fulton DR; Lo MS; Baker AL; Sundel RP; Newburger JW
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.